Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen

Bruce K. Patterson, Dennis J. Carlo, Mark H. Kaplan, Maria Marecki, Savita G Pahwa, Ronald B. Moss

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objective: We examined the effect of an HIV-1-specific immune-based therapy on cell-associated HIV-1 DNA and RNA. Design: Five HIV-1-infected subjects receiving HIV-1 immunogen plus HAART were compared with three HIV-1-infected subjects who received incomplete Freund's adjuvant (IFA) plus HAART. Methods: Cell-associated HIV-1 RNA or DNA in lymphocytes and monocytes was determined using a dual immunophenotyping/in situ hybridization assay with or without in situ PCR amplification. Results: Cell-associated HIV-1 RNA in CD4 cells correlated with plasma RNA overall. CD4, HIV-1 gag-pol messenger (m)RNA+ cells decreased in the immunogen plus HAART group compared with the IFA plus HAART group. Decreases in HIV-1 DNA+ CD4 cells were observed in the immunogen plus HAART compared with the IFA plus HAART group. Decreases in HIV-1 gag-pol mRNA+ monocytes were observed in the immunogen plus HAART group compared with the IFA plus HAART group. Consistent with the findings in CD4 cells, decreases in HIV-1 DNA+ monocytes were observed in the immunogen plus HAART group compared with the IFA plus HAART group. Conclusions: These preliminary observations support the rationale for examining the combination of immune-based therapies and antiretroviral drugs for effective HIV-1 control.

Original languageEnglish (US)
Pages (from-to)1607-1611
Number of pages5
JournalAIDS
Volume13
Issue number13
DOIs
StatePublished - Dec 1 1999
Externally publishedYes

Fingerprint

Highly Active Antiretroviral Therapy
Helper-Inducer T-Lymphocytes
HIV-1
Monocytes
Messenger RNA
DNA
RNA
Immunophenotyping
Cell- and Tissue-Based Therapy
In Situ Hybridization
incomplete Freund's adjuvant
Lymphocytes

Keywords

  • CD14
  • CD4
  • Flow cytometry
  • HIV-1 viral load
  • In situ hybridization

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen. / Patterson, Bruce K.; Carlo, Dennis J.; Kaplan, Mark H.; Marecki, Maria; Pahwa, Savita G; Moss, Ronald B.

In: AIDS, Vol. 13, No. 13, 01.12.1999, p. 1607-1611.

Research output: Contribution to journalArticle

Patterson, Bruce K. ; Carlo, Dennis J. ; Kaplan, Mark H. ; Marecki, Maria ; Pahwa, Savita G ; Moss, Ronald B. / Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen. In: AIDS. 1999 ; Vol. 13, No. 13. pp. 1607-1611.
@article{5c232e5be69643e7b7424467bb9fd72b,
title = "Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen",
abstract = "Objective: We examined the effect of an HIV-1-specific immune-based therapy on cell-associated HIV-1 DNA and RNA. Design: Five HIV-1-infected subjects receiving HIV-1 immunogen plus HAART were compared with three HIV-1-infected subjects who received incomplete Freund's adjuvant (IFA) plus HAART. Methods: Cell-associated HIV-1 RNA or DNA in lymphocytes and monocytes was determined using a dual immunophenotyping/in situ hybridization assay with or without in situ PCR amplification. Results: Cell-associated HIV-1 RNA in CD4 cells correlated with plasma RNA overall. CD4, HIV-1 gag-pol messenger (m)RNA+ cells decreased in the immunogen plus HAART group compared with the IFA plus HAART group. Decreases in HIV-1 DNA+ CD4 cells were observed in the immunogen plus HAART compared with the IFA plus HAART group. Decreases in HIV-1 gag-pol mRNA+ monocytes were observed in the immunogen plus HAART group compared with the IFA plus HAART group. Consistent with the findings in CD4 cells, decreases in HIV-1 DNA+ monocytes were observed in the immunogen plus HAART group compared with the IFA plus HAART group. Conclusions: These preliminary observations support the rationale for examining the combination of immune-based therapies and antiretroviral drugs for effective HIV-1 control.",
keywords = "CD14, CD4, Flow cytometry, HIV-1 viral load, In situ hybridization",
author = "Patterson, {Bruce K.} and Carlo, {Dennis J.} and Kaplan, {Mark H.} and Maria Marecki and Pahwa, {Savita G} and Moss, {Ronald B.}",
year = "1999",
month = "12",
day = "1",
doi = "10.1097/00002030-199909100-00002",
language = "English (US)",
volume = "13",
pages = "1607--1611",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "13",

}

TY - JOUR

T1 - Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen

AU - Patterson, Bruce K.

AU - Carlo, Dennis J.

AU - Kaplan, Mark H.

AU - Marecki, Maria

AU - Pahwa, Savita G

AU - Moss, Ronald B.

PY - 1999/12/1

Y1 - 1999/12/1

N2 - Objective: We examined the effect of an HIV-1-specific immune-based therapy on cell-associated HIV-1 DNA and RNA. Design: Five HIV-1-infected subjects receiving HIV-1 immunogen plus HAART were compared with three HIV-1-infected subjects who received incomplete Freund's adjuvant (IFA) plus HAART. Methods: Cell-associated HIV-1 RNA or DNA in lymphocytes and monocytes was determined using a dual immunophenotyping/in situ hybridization assay with or without in situ PCR amplification. Results: Cell-associated HIV-1 RNA in CD4 cells correlated with plasma RNA overall. CD4, HIV-1 gag-pol messenger (m)RNA+ cells decreased in the immunogen plus HAART group compared with the IFA plus HAART group. Decreases in HIV-1 DNA+ CD4 cells were observed in the immunogen plus HAART compared with the IFA plus HAART group. Decreases in HIV-1 gag-pol mRNA+ monocytes were observed in the immunogen plus HAART group compared with the IFA plus HAART group. Consistent with the findings in CD4 cells, decreases in HIV-1 DNA+ monocytes were observed in the immunogen plus HAART group compared with the IFA plus HAART group. Conclusions: These preliminary observations support the rationale for examining the combination of immune-based therapies and antiretroviral drugs for effective HIV-1 control.

AB - Objective: We examined the effect of an HIV-1-specific immune-based therapy on cell-associated HIV-1 DNA and RNA. Design: Five HIV-1-infected subjects receiving HIV-1 immunogen plus HAART were compared with three HIV-1-infected subjects who received incomplete Freund's adjuvant (IFA) plus HAART. Methods: Cell-associated HIV-1 RNA or DNA in lymphocytes and monocytes was determined using a dual immunophenotyping/in situ hybridization assay with or without in situ PCR amplification. Results: Cell-associated HIV-1 RNA in CD4 cells correlated with plasma RNA overall. CD4, HIV-1 gag-pol messenger (m)RNA+ cells decreased in the immunogen plus HAART group compared with the IFA plus HAART group. Decreases in HIV-1 DNA+ CD4 cells were observed in the immunogen plus HAART compared with the IFA plus HAART group. Decreases in HIV-1 gag-pol mRNA+ monocytes were observed in the immunogen plus HAART group compared with the IFA plus HAART group. Consistent with the findings in CD4 cells, decreases in HIV-1 DNA+ monocytes were observed in the immunogen plus HAART group compared with the IFA plus HAART group. Conclusions: These preliminary observations support the rationale for examining the combination of immune-based therapies and antiretroviral drugs for effective HIV-1 control.

KW - CD14

KW - CD4

KW - Flow cytometry

KW - HIV-1 viral load

KW - In situ hybridization

UR - http://www.scopus.com/inward/record.url?scp=0033385794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033385794&partnerID=8YFLogxK

U2 - 10.1097/00002030-199909100-00002

DO - 10.1097/00002030-199909100-00002

M3 - Article

VL - 13

SP - 1607

EP - 1611

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 13

ER -